Novel drug discovery system for cancer stem cells in human squamous cell carcinoma of the esophagus

Oncology Reports

Volumn 31, Issue 3, 2014, Pages 1133-1138

  Kano, Yoshihiro ^a   Konno, Masamitsu ^a   Kawamoto, Koichi ^a   Tamari, Keisuke ^a   Hayashi, Kazuhiko ^a   Fukusumi, Takahito ^a   Satoh, Taroh ^a   Tanaka, Shinji ^b   Ogawa, Kazuhiko ^a   Mori, Masaki ^a   Doki, Yuichiro ^a   Ishii, Hideshi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Esophageal cancer; Novel drug discovery; Ornithine decarboxylase

Indexed keywords

CISPLATIN; FLUORESCEIN DERIVATIVE; FLUOROURACIL; HYBRID PROTEIN; JANUS KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; ORNITHINE DECARBOXYLASE; PROTEIN KINASE B INHIBITOR; RETROVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STEM CELL; CARBOXY TERMINAL SEQUENCE; CARCINOGENICITY; CELL RENEWAL; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SCREENING; DRUG SENSITIVITY; DRUG STRUCTURE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IC 50; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RADIOSENSITIVITY;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; GREEN FLUORESCENT PROTEINS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASTIC STEM CELLS; RADIATION TOLERANCE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84896694472     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2952     Document Type: Article

References (16)

1. Cheng KK and Day NE: Nutrition and esophageal cancer. Cancer Causes Control 7: 33-40, 1996. (Pubitemid 26066850)
2. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003. (Pubitemid 36418143)
3. Dembinski JL and Krauss S: Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma. Clin Exp Metastasis 26: 611-623, 2009.
4. Tang KH, Dai YD, Tong M, et al: A CD90+ tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer. Cancer Res 73: 2322-2332, 2013.
5. Li H, Gao Q, Guo L and Lu SH: The PTEN/PI3K/Akt pathway regulates stem-like cells in primary esophageal carcinoma cells. Cancer Biol Ther 11: 950-958, 2011.
6. Zhao JS, Li WJ, Ge D, et al: Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44. PLoS One 6: e21419, 2011.
7. Huang SD, Yuan Y, Liu XH, et al: Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas. BMC Cancer 9: 9, 2009.
8. Kano Y, Konno M, Ohta K, et al: Jumonji/Arid1b (Jarid1b) protein modulates human esophageal cancer cell growth. Mol Clin Oncol 1: 753-757, 2013.
9. Vlashi E, Kim K, Lagadec C, et al: In vivo imaging, tracking, and targeting of cancer stem cells. J Natl Cancer Inst 101: 350-359, 2009.
10. Pan J, Zhang Q, Wang Y, et al: 26S proteasome activity is down-regulated in lung cancer stem-like cells propagated in vitro. PLoS One 5: e13298, 2010.
11. Adikrisna R, Tanaka S, Muramatsu S, et al: Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents. Gastroenterology 143: 234-245.e7, 2012.
12. Della Donna L, Lagadec C and Pajonk F: Radioresistance of prostate cancer cells with low proteasome activity. Prostate 72: 868-874, 2012.
13. Muramatsu S, Tanaka S, Mogushi K, et al: Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course. Hepatology 58: 218-228, 2013.
14. + primary colon cancer cells. Carcinogenesis 31: 1376-1380, 2010.
15. Iwanaga R, Wang CA, Micalizzi DS, et al: Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways. Breast Cancer Res 14: R100, 2012.
16. Hernandez-Vargas H, Ouzounova M, Le Calvez-Kelm F, et al: Methylome analysis reveals Jak-STAT pathway deregulation in putative breast cancer stem cells. Epigenetics 6: 428-439, 2011.